$GBT: Global Blood Therapeutics Prices a $150.0 Million Common Stock …

Date: Friday, December 7th, 2018

Stock(s) mentioned:

Source: Benzinga (https://www.benzinga.com)

Summary: 07, 2018 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a clinical-stage biopharmaceutical company determined to discover, …

Full article address: https://www.benzinga.com/pressreleases/18/12/g12815417/global-blood-therapeutics-prices-a-150-0-million-common-stock-public-o

Related News:

$GBT: GBT Appoints Dawn Svoronos to Board of Directors

$GBT: Here’s Why Global Blood Therapeutics Fell 10.1% in November …

$GBT: How Global Blood Therapeutics Is Capitalizing on Its Sickle Cell …

$GBT: Global Blood prices stock offering; shares down 6% premarket

$GBT: Global Blood Therapeutics Delivers The Good News; What Is The …

$GBT: Global Blood launches $150M stock offering; shares down 4% after …

$GBT: Global Blood Therapeutics Announces Proposed Public Offering of …

$GBT: GBT Announces New Employment Inducement Grants

$GBT: Global Blood Therapeutics Options Pop on FDA Buzz

$GBT $ATOS $BHVN: Healthcare and Industrial goods dominate midday movers

$GBT: Global Blood’s Sickle Cell Disease Drug Snags Accelerated FDA …

Latest News:

$MESO: Mesoblast’s (MESO) CEO Silviu Itescu on First Half Year and …

$XPER: Xperi Corporation (XPER) CEO Jon Kirchner on Q4 2018 Results …

$PI: Impinj, Inc. (PI) CEO Chris Diorio on Q4 2018 Results – Earnings …

$PEGA: Pegasystems (PEGA) Q4 2018 Earnings Conference Call Transcript

$SNPS: Synopsys Inc (SNPS) Q1 2019 Earnings Conference Call Transcript

$EVTC: EVERTEC, Inc. (EVTC) CEO Morgan Schuessler on Q4 2018 …

$CGC: Canopy Growth Corporation Files Amended and Restated Third …

$FB: Regulatory Pressures On Facebook And Their Impact

$SEDG: Solaredge Technologies, Inc. (SEDG) CEO Guy Sella on Q4 2018 …

$NKE $SPX: Zion Williamson blows out his shoe, injures knee, and Nike gasps in horror

$FANG $CXO: More Permian Basin Drillers Are Tapping the Brakes in 2019